Qilian International Holding Group Ltd
NASDAQ:QLI
Qilian International Holding Group Ltd
NASDAQ:QLI
Price:
7.18
USD
0.42%
Market Cap:
$51.9m
Relative Value
There is not enough data to reliably calculate the relative value of QLI.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
QLI
Relative Value
Base Case
Not Available
Multiples Across Competitors
QLI Competitors Multiples
Qilian International Holding Group Ltd Competitors
Qilian International Holding Group Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CN |
|
Qilian International Holding Group Ltd
NASDAQ:QLI
|
51.3m USD | 1.1 | -6.6 | -20 | -11.3 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
908.7B USD | 13.5 | 42.6 | 28.8 | 30.7 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
581.3B USD | 6.1 | 21.5 | 15 | 18.4 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
256.6B CHF | 4.2 | 19.9 | 11.8 | 13.3 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
224.3B GBP | 5.1 | 29.2 | 16.2 | 22.8 | |
| CH |
|
Novartis AG
SIX:NOVN
|
233.8B CHF | 5.4 | 21.6 | 13.3 | 17.1 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
288.4B USD | 4.4 | 15.7 | 9.7 | 11.9 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD | 94 | -74.6 | 344.9 | 865 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.6 | 11 | 8.1 | 9.5 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
154.5B USD | 2.5 | 19.9 | 7.7 | 10.2 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
122B USD | 2.5 | 17.3 | 7.3 | 8.9 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
